Polygenic and multifactorial scores for pancreatic ductal adenocarcinoma risk prediction

Most cases of pancreatic ductal adenocarcinoma (PDAC) are asymptomatic in early stages, and the disease is typically diagnosed in advanced phases, resulting in very high mortality. Tools to identify individuals at high risk of developing PDAC would be useful to improve chances of early detection.We...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerzők: Galeotti Alice Alessandra
Gentiluomo Manuel
Rizzato Cosmeri
Obazee Ofure
Neoptolemos John P
Pasquali Claudio
Nentwich Michael
Cavestro Giulia Martina
Pezzilli Raffaele
Greenhalf William
Holleczek Bernd
Hegyi Péter
Darvasi Erika
Szmola Richárd
Szentesi Andrea Ildikó
Dokumentumtípus: Cikk
Megjelent: 2021
Sorozat:JOURNAL OF MEDICAL GENETICS 58 No. 6
doi:10.1136/jmedgenet-2020-106961

mtmt:31363361
Online Access:http://publicatio.bibl.u-szeged.hu/21972
LEADER 02923nab a2200373 i 4500
001 publ21972
005 20210729095422.0
008 210729s2021 hu o 0|| zxx d
022 |a 0022-2593 
024 7 |a 10.1136/jmedgenet-2020-106961  |2 doi 
024 7 |a 31363361  |2 mtmt 
040 |a SZTE Publicatio Repozitórium  |b hun 
041 |a zxx 
100 1 |a Galeotti Alice Alessandra 
245 1 0 |a Polygenic and multifactorial scores for pancreatic ductal adenocarcinoma risk prediction  |h [elektronikus dokumentum] /  |c  Galeotti Alice Alessandra 
260 |c 2021 
300 |a 369-377 
490 0 |a JOURNAL OF MEDICAL GENETICS  |v 58 No. 6 
520 3 |a Most cases of pancreatic ductal adenocarcinoma (PDAC) are asymptomatic in early stages, and the disease is typically diagnosed in advanced phases, resulting in very high mortality. Tools to identify individuals at high risk of developing PDAC would be useful to improve chances of early detection.We generated a polygenic risk score (PRS) for PDAC risk prediction, combining the effect of known risk SNPs, and carried out an exploratory analysis of a multifactorial score.We tested the associations of the individual known risk SNPs on up to 2851 PDAC cases and 4810 controls of European origin from the PANcreatic Disease ReseArch (PANDoRA) consortium. Thirty risk SNPs were included in a PRS, which was computed on the subset of subjects that had 100% call rate, consisting of 839 cases and 2040 controls in PANDoRA and 6420 cases and 4889 controls from the previously published Pancreatic Cancer Cohort Consortium I-III and Pancreatic Cancer Case-Control Consortium genome-wide association studies. Additional exploratory multifactorial scores were constructed by complementing the genetic score with smoking and diabetes.The scores were associated with increased PDAC risk and reached high statistical significance (OR=2.70, 95% CI 1.99 to 3.68, p=2.54×10-10 highest vs lowest quintile of the weighted PRS, and OR=14.37, 95% CI 5.57 to 37.09, p=3.64×10-8, highest vs lowest quintile of the weighted multifactorial score).We found a highly significant association between a PRS and PDAC risk, which explains more than individual SNPs and is a step forward in the direction of the construction of a tool for risk stratification in the population. 
700 0 1 |a Gentiluomo Manuel  |e aut 
700 0 1 |a Rizzato Cosmeri  |e aut 
700 0 1 |a Obazee Ofure  |e aut 
700 0 1 |a Neoptolemos John P  |e aut 
700 0 1 |a Pasquali Claudio  |e aut 
700 0 1 |a Nentwich Michael  |e aut 
700 0 1 |a Cavestro Giulia Martina  |e aut 
700 0 1 |a Pezzilli Raffaele  |e aut 
700 0 1 |a Greenhalf William  |e aut 
700 0 1 |a Holleczek Bernd  |e aut 
700 0 1 |a Hegyi Péter  |e aut 
700 0 1 |a Darvasi Erika  |e aut 
700 0 1 |a Szmola Richárd  |e aut 
700 0 1 |a Szentesi Andrea Ildikó  |e aut 
856 4 0 |u http://publicatio.bibl.u-szeged.hu/21972/1/GaleottiJMedGenet2021.pdf  |z Dokumentum-elérés